Loading…
Antiepileptic drugs alter the expression of placental carriers: An in vitro study in a human placental cell line
Summary Objective Antiepileptic drugs (AEDs) affect the expression of carriers for drugs and nutrients at several blood‐tissue barriers, but their impact on placental carriers is largely unknown. Our aim was to study the effects of AEDs in human placental cells on the expression of carriers for horm...
Saved in:
Published in: | Epilepsia (Copenhagen) 2015-07, Vol.56 (7), p.1023-1032 |
---|---|
Main Authors: | , , |
Format: | Article |
Language: | English |
Subjects: | |
Citations: | Items that this one cites Items that cite this one |
Online Access: | Get full text |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Summary: | Summary
Objective
Antiepileptic drugs (AEDs) affect the expression of carriers for drugs and nutrients at several blood‐tissue barriers, but their impact on placental carriers is largely unknown. Our aim was to study the effects of AEDs in human placental cells on the expression of carriers for hormones, nutrients, and drugs: folate placental uptake carriers (reduced folate carrier, RFC; folate receptor α, FRα) and efflux transporters (breast cancer resistance protein, BCRP and multidrug resistance protein 2) and thyroid hormone uptake transporters (l‐type amino acid transporter‐LAT1 and organic anion transporting polypeptides‐OATPs).
Methods
The human trophoblast BeWo cells were incubated with phenytoin (PHT), valproic acid (VPA), carbamazepine (CBZ), levetiracetam (LEV), lamotrigine (LTG), or their vehicles at concentrations that mostly represent their therapeutic range. RT‐PCR and western blot analysis were utilized to study the effects of AEDs on carriers’ mRNA and protein expression, respectively. The activity of BCRP was evaluated by accumulation studies.
Results
Compared with controls, VPA‐treated cells displayed half the levels of RFC mRNA and protein (p |
---|---|
ISSN: | 0013-9580 1528-1167 |
DOI: | 10.1111/epi.13037 |